Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging

Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joseph Flores, Anastasia Noël, Bénédicte Foveau, Olivier Beauchet, Andréa C. LeBlanc
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/f9e708e8e4a94657bdc8e388bc81fd42
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f9e708e8e4a94657bdc8e388bc81fd42
record_format dspace
spelling oai:doaj.org-article:f9e708e8e4a94657bdc8e388bc81fd422021-12-02T17:42:11ZPre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging10.1038/s41467-020-18405-92041-1723https://doaj.org/article/f9e708e8e4a94657bdc8e388bc81fd422020-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-18405-9https://doaj.org/toc/2041-1723Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the onset of deficits.Joseph FloresAnastasia NoëlBénédicte FoveauOlivier BeauchetAndréa C. LeBlancNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Joseph Flores
Anastasia Noël
Bénédicte Foveau
Olivier Beauchet
Andréa C. LeBlanc
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
description Previous work showed that the caspase 1 inhibitor VX-765 rescued cognitive deficits in the J20 mouse model of Alzheimer’s disease, and this may occur via reduced inflammation. Here the authors show that administration of the drug prior to onset of cognitive deficits and pathology in mice delays the onset of deficits.
format article
author Joseph Flores
Anastasia Noël
Bénédicte Foveau
Olivier Beauchet
Andréa C. LeBlanc
author_facet Joseph Flores
Anastasia Noël
Bénédicte Foveau
Olivier Beauchet
Andréa C. LeBlanc
author_sort Joseph Flores
title Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_short Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_full Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_fullStr Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_full_unstemmed Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
title_sort pre-symptomatic caspase-1 inhibitor delays cognitive decline in a mouse model of alzheimer disease and aging
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/f9e708e8e4a94657bdc8e388bc81fd42
work_keys_str_mv AT josephflores presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT anastasianoel presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT benedictefoveau presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT olivierbeauchet presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
AT andreacleblanc presymptomaticcaspase1inhibitordelayscognitivedeclineinamousemodelofalzheimerdiseaseandaging
_version_ 1718379682320089088